CLEARMIND MEDICINE INC. (CMND)
Clearmind Medicine Completes Dosing for Part A of its of FDA-Regulated Phase I/II Clinical Trial
Clearmind Medicine Completes Dosing for Part A of its of FDA-Regulated Phase I/II Clinical Trial
Opening of Trading On Wednesday, June 17 2026-MIVNE B27
Almonty Industries Provides Update on Large-Scale Drilling Program at Sangdong Molybdenum Project
Research and AI Momentum, Record Margins, and Cash Flow Growth Highlight Wileys Fourth Quarter and Fiscal 2026 Results
Pizza Factory Selects PAR Technology’s Unified Platform to Power Restaurant Operations and Digital Growth
Julong Holding Limited Announces Changes to Its Board of Directors and Board Committees
ZenaTech’s ZenaDrone Prepares the IQ Quad Land Survey Drone for Submission for Blue UAS Certification to Enable U.S. Government and Defense Procurement Readiness
Monro, Inc. Publishes Sixth Annual Environmental, Social, and Governance (ESG) Report
FreightCar America Appoints Bradley J. Pickard to Board of Directors
Stardust Power Advances Execution Readiness at Muskogee Lithium Refinery